登录查看更多内容

Medical Device Developments Weekly

Medical Device Developments

Latest news and insight on innovations in the Medical Device sector.

发布日期: 2024年6月26日

+ 关注

RAPID + TCT 2024: AM IN LOS ANGELES On June 25-27, 2024, RAPID + TCT will return to the West Coast for the first time in nearly a decade! The three-day event will feature the latest in 3D-printing technology from the industry’s leading product and service providers, a full schedule of speakers including a keynote series, and over 125 hours of educational content. The expansive show floor will showcase over 400 exhibiting companies’ latest advancements. Start planning your trip to sunny Southern California to experience North America’s largest additive manufacturing and industrial 3D printing event!

Welcome to this week's Medical Device Developments newsletter.

See the latest insight and analysis from the global medical device market from the last week below:

OSSIO launches OSSIOfiber compression staples for hand and foot surgeries

The American orthopedic fixation company is engaged in developing bio-integrative fixation implants that leave no permanent residue.

The OSSIOfiber small compression staples enhance OSSIO’s portfolio, which includes larger compression staples, suture anchors, trimmable fixation nails, compression screws, and a hammertoe fixation system.

OmnifyXR is an advanced augmented reality (AR) based interventional radiology suite, developed by MediView XR, Inc. XR, in collaboration with GE HealthCare .

The radiology suite combines a holographic heads-up display streaming live medical imaging, 3D anatomy model visualisation and advanced imaging technologies.

Currently, Merit Medical Systems, Inc. is supplying Medtronic ’s Kyphon Xpander Inflation Syringes used to reduce fractures and create a void in the vertebral body during balloon kyphoplasty procedures.

Under the expanded partnership, Medtronic will carry out the sales, marketing, and distribution of the Kyphon KyphoFlex unipedicular balloon catheter.

Why Medical Device Developments is the first choice for medical device manufacturing professionals The authoritative voice of the medical device industry, Medical Device Developments is leading the debate on the evolution of the market through extensive research, data analysis, policy reports and up-to-the-minute reporting from the medical device industry. Medical Device Developments is the premier information source for the world’s major medical device manufacturers/OEMs to help them make critical business decisions. Aimed at senior executives, Medical Device Developments provides a clear overview of the latest thinking regarding the role of technology. Medical Device Developments is supported across a number of platforms online and is positioned as the definitive destination for medical device manufacturing professionals. We are driven by unbiased and authoritative editorial content brought to you by an expert team of journalists with unrivalled industry expertise.

Co-Diagnostics, Inc files FDA 510(k) application for Co-Dx PCR Pro platform

The Co-Dx PCR platform aims to address the gap in access to infectious disease diagnostics by enabling widespread decentralisation of polymerase chain reaction testing.

Persistence Market Research (UK) 8 个月前

Medical Device Developments Weekly

Medical Device Developments 6 个月前

Surgical Monitor Market Research Report 2024

Market Research Ideas 6 个月前

According to Co-Diagnostics, Inc , the platform features a compact, robust real-time PCR instrument designed for use in point-of-care or at-home settings.

VitaFlow Liberty, which prevents open-heart surgery and provides several benefits to patients, is the world’s only electric retrievable transcatheter aortic valve system and is widely used as a preferred choice for aortic heart valve disease.

Before the commercial launch in the EU market, the company conducted pre-market clinical implantations of VitaFlow Liberty in Ireland, Denmark, and the UK

The Cordella Sensor is an implantable pulmonary artery (PA) pressure sensor that directly measures PA, the indicator of congestion, allowing early, targeted therapy.

It is indicated for patients with New York Heart Failure (NYHA) class 3 heart failure (HF).

Bringing together experts from a variety of industries for face-to-face and virtual events, diner clubs and conferences

Upcoming webinars

H&T Presspart: Transitioning pMDI’s products with Low Global Warming Propellants

Recommended webinars

Meridian Bioscience: The Evolution of STI At-Home Testing Solutions
DuPont Liveo: Introducing new DuPont? Liveo? MG 7-9960 Soft Skin Adhesive
WuxiApptec: Designing Extractable/Leachable Studies for Drugs and Biologics
Loftware Siemens: The challenge of labeling & UDI for medical device
Particle Measuring Systems: Environmental Monitoring Compliance Learning from FDA Warning Letters
Rockwell Automation: A Unified Data Platform Delivers Integrated PAT and CPV

Thanks for reading; we hope you enjoyed it.

Until next week.

To have a story featured on next week's newsletter - contact Medical Device Developments or Jamie Mann directly.

#MedicalDeviceDevelopments

Medical Device Developments Weekly